<SEC-DOCUMENT>0001193125-14-213107.txt : 20140527
<SEC-HEADER>0001193125-14-213107.hdr.sgml : 20140526
<ACCEPTANCE-DATETIME>20140527170736
ACCESSION NUMBER:		0001193125-14-213107
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20140527
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20140527
DATE AS OF CHANGE:		20140527

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MILESTONE SCIENTIFIC INC.
		CENTRAL INDEX KEY:			0000855683
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				133545623
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14053
		FILM NUMBER:		14870561

	BUSINESS ADDRESS:	
		STREET 1:		220 SOUTH ORANGE AVENUE
		CITY:			LIVINGSTON
		STATE:			NJ
		ZIP:			07039
		BUSINESS PHONE:		(973) 535-2717

	MAIL ADDRESS:	
		STREET 1:		220 SOUTH ORANGE AVENUE
		CITY:			LIVINGSTON
		STATE:			NJ
		ZIP:			07039

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MILESTONE SCIENTIFIC INC/NJ
		DATE OF NAME CHANGE:	19970409

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	U S OPPORTUNITY SEARCH INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d733962d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant
to Section&nbsp;13 or 15(d) of the </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported) May&nbsp;27, 2014 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>MILESTONE SCIENTIFIC INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of Registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>0-26284</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>13-3545623</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(IRS Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>220 South Orange Avenue, Livingston Corporate Park, Livingston, New Jersey 07034 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive office) (Zip Code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Registrant&#146;s telephone number, including area code (973)&nbsp;535-2717 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>N/A </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former name or
former address, if changed since last report) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;5.02</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Election of Directors and Appointment of Certain Officers </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May&nbsp;14, 2014, the
Board of Directors (the &#147;Board&#148;) of Milestone Scientific Inc. (the &#147;Company&#148;) increased the size of the Board from four to five members and appointed Gian Domenico Trombetta to fill the vacancy created by such expansion. He was
also appointed as President and Chief Executive Officer of the Company&#146;s newly created dental division. Mr.&nbsp;Trombetta assumed office as a Director and as the President and Chief Executive Officer of the dental division on May&nbsp;27,
2014. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Trombetta&#146;s compensation arrangement with the Company has not been determined as of the date of the filing of this
report. He has not had any direct or indirect interest in any transactions with the Company that requires disclosure under Item&nbsp;404(a) of Regulation S-K, except that on May&nbsp;14, 2014, the Company completed a $10 million private placement
financing with BP 4 Srl, an affiliate of the Milan based private equity investor Innovest S.p.A. Mr.&nbsp;Trombetta is the President and CEO of Innovest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There is no existing family relationship between Mr.&nbsp;Trombetta and any director or executive officer of the Company. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BIOGRAPHICAL INFORMATION REGARDING THE INCOMING DIRECTOR </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The principal occupation and brief summary of Mr.&nbsp;Trombetta&#146;s background is as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Gian Domenico Trombetta</B>, age 53, has been the President and Chief Executive Officer of the Company&#146;s Dental Division since May,
2014. He founded Innovest S.p.A. in 1993, a private equity and special situation investment firm and has been its President and CEO since 1996. He serves as the Chief Executive Officer or a board member of numerous private commercial companies. He
was a project Manager for Booz Allen and Hamilton, Inc., a strategy and acquisition services firm, from 1988 to 1992. Mr.&nbsp;Trombetta holds a degree in business administration from Luiss University in Rome, Italy and a MBA degree from Insead in
Fontainebleau, France. <B> </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;8.01.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Other Events </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May&nbsp;27, 2014, the Company issued a press release announcing that
it had appointed Mr.&nbsp;Trombetta to the Board and as President and Chief Executive Officer of its dental division. The press release is attached as Exhibit 99.1 hereto. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Financial Statements and Exhibits </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit<BR>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:39.50pt; font-size:8pt; font-family:Times New Roman"><B>Description</B></P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press release dated May 27, 2014</TD></TR>
</TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;* </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>MILESTONE SCIENTIFIC INC.</B></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Joseph D&#146;Agostino</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Joseph D&#146;Agostino</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Chief Financial Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: May&nbsp;27, 2014 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d733962dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g733962snap0002.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Relations: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Waldman or Natalya Rudman </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Crescendo Communications, LLC
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email: mlss@crescendo-ir.com </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tel: 212-671-1020 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Milestone Scientific Appoints Gian Domenico Trombetta as President&nbsp;&amp; CEO of its Dental Division </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Joins Milestone Scientific Board of Directors </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>LIVINGSTON, NJ, May&nbsp;27, 2014 &#151; Milestone Scientific Inc. (OTCQB: MLSS)</B>, a leading medical research and development company that designs and
patents innovative injection technology, today announced that it has appointed Gian Domenico Trombetta as Chief Executive Officer of its dental division. Mr.&nbsp;Trombetta will also serve as a member of Milestone Scientific&#146;s Board of
Directors. Leonard Osser will remain Chief Executive Officer of Milestone Scientific. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Trombetta is the President and CEO of Innovest S.p.A., a
Milan based private equity and special situation investment company with a specific focus on innovative investment niches. In the past he has served as CEO and board member of numerous private commercial companies. Mr.&nbsp;Trombetta&#146;s
appointment follows the recent announcement on May&nbsp;15, 2014 of a $10 million private placement into Milestone Scientific led by Innovest S.p.A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Leonard Osser, CEO of Milestone Scientific, stated, &#147;We welcome the addition of Gian Domenico as President and CEO of our dental division and a member of
the board of directors. He brings years of senior management experience and an impressive track record leading high growth companies across a broad range of industries. As President and CEO of the dental division, he will oversee an expanded
initiative to more aggressively market our instruments and handpieces on a global basis. His appointment also allows us to focus greater resources towards developing and commercializing new instruments for a wide array of medical applications.&#148;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gian Domenico Trombetta, CEO of Innovest S.p.A., commented, &#147;I am pleased to join Milestone Scientific&#146;s management team as well as the board
of directors. Milestone has accomplished a great deal in building market awareness and penetration of its dental instrument. With the additional resources and capital from us, we look forward to expanding sales of the instrument in both the domestic
and international markets. In addition, with our recent capital infusion we look forward to helping accelerate the launch of new medical instruments based on Milestone&#146;s proven technology.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Milestone Scientific Inc. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Milestone Scientific is
a leading medical research and development company that designs and patents innovative injection technology. Milestone&#146;s computer-controlled systems make injections precise, efficient, and virtually painless. For more information please visit
our website: <U>www.milestonescientific.com</U>. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Safe Harbor Statement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This press release contains forward-looking statements regarding the timing and financial impact of Milestone&#146;s ability to implement its business plan,
expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all
of which are difficult or impossible to predict accurately and many of which are beyond Milestone&#146;s control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking
statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and
standards, and the risk factors detailed from time to time in Milestone&#146;s periodic filings with the Securities and Exchange Commission, including without limitation, Milestone&#146;s Annual Report for the year ended December&nbsp;31, 2013. The
forward looking-statements in this press release are based upon management&#146;s reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason. </I></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g733962snap0002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g733962snap0002.jpg
M_]C_X``02D9)1@`!``$`8`!@``#__@`?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$``@&!@<&!0@'!P<*"0@*#18.#0P,#1L3%!`6(!PB(1\<
M'QXC*#,K(R8P)AX?+#TM,#4V.3HY(BL_0SXX0S,X.3<!"0H*#0L-&@X.&C<D
M'R0W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W
M-S<W-S<W-__$`:(```$%`0$!`0$!```````````!`@,$!08'"`D*"P$``P$!
M`0$!`0$!`0````````$"`P0%!@<("0H+$``"`0,#`@0#!04$!````7T!`@,`
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1``(!`@0$`P0'!00$``$"=P`!`@,1
M!`4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_``!$(`#H`\@,!$0`"$0$#$0'_V@`,
M`P$``A$#$0`_`/4?%/BR_P##LN]-,2XM,#,@DPRGW&.GO6M.$9NS9,FUJ0^%
M?'JZ_>R6D]LMO(!E,-G<.]75HNFKBC*YVE<Y8A.!F@#@-<^))TS69+"TL!=;
M"$SOP2Y[5TQH7AS-V(<[.R.JT'4KS4;,2WMO'!*3]V-BP`^I`YKG=KZ%FM2`
M*`"@`H`*`"@`H`*`"@`H`*`"@`H`*`(9KNWMO]=,D?\`O'%%@(8]4L97")=Q
M%CT&X9-&PTF]BV"".#0(6@`H`*`"@`H`*`"@`H`P_%5K#-H-V9$!Q&W\JJ'Q
M(3V/"])U)M/U*&[B)W0OR.F1WKU)Q4XM'.G9GT+IMY'?6$-Q&V5=00:\IJSL
M=)G^*M:30M!N+MCA@N$'JQZ55./-*PF[(\.TYVFURT>;)9[A2V[KDFO2J)>S
M=C!?$>[S71TS25F@M#.P`_=HP4G\3Q7EK?4Z#F8?B;:SW:6D6E71N';9L8JN
M".N3GVK9T&H\U]"%.[L=!J_B!M*LDNEL);I",N(F&5'K@]?PK*,4W:Y3=C'T
MGXA6NLWZ6EKI\^3RSL5`0>OO6E2BZ:NV)2OL=D#E0:Q*.=\0^*QX><&73IYX
M,<RQD84^A'6M(0Y]+DMV,JT^(\%]O^R:/>3!#AB"H`/XFJE2Y'9L2E<N:5XY
M@U+61I<FGW-I.4+CS<8(&/3ZTG3M'F3&I:V-;7-?L]!M5EN=SO(P2**,99V/
M0`5$8N0V[&&WCT6@\S4M(N+6W_YZAED"_7'2K5-2T3$W;<V(/$ME<Z`VL1!S
M;JA?!X/&?\*EP:ERCOI<YV+XFP30^='HFH-%C(=5!&/7K5^R2=KBYO(2+XHV
M4[[(-*O97`R0@!P/SJI4.7=B4[FAH_CRVU;5_P"S6L+FUFV%QYP`R*B5*T>9
M,:EK8F\2>()+1UL+$C[4XR6Z[!_C6+=CMP^']IK+8YR-)HP9;UY))-W`8<D?
M6JC*VYTU,-%NT%\R?^SX+A81(3M4ELXY/XUNZ=T<,,2Z;DDM30M==;2YHX9-
MS6^<%V/W><#ZUE423LA0IRG'F+&N>-X="E43:?/)"^-LR$%2?3U%53I\^B9A
M)\NYIZ!XBLO$%F)[4E3T:-C\RGWJ9P<'9C3N/UO6'T>V$RV,MV/XEB(!4>N#
MUI12;!F9H'C2#Q#(_P!GL9HH4X,DA`R?0#K53I\CLV).Y1U'XBP:3=M;WNE7
M43#.&RI##U!!JX4>=:,3E;<<GQ`,EN)X]!OFC(W`@IR/IFHY$G:Y5S8\-^)K
M?Q):O/!#)#L<H4DZ@BE.'(["3N;E048OBIMGAR]/_3-OY5</B0GL>*3:2R^&
M;35(UX!*R?0L<'\_YUVPG:JXLQ:]VYWWPRUL26DFFRO\T/*9_NFL<3"TKHN#
MNK$7B:=O$GBV+2XCFUL/WDN.A?\`A']:A>Y#S96[.""^1XD1/[EV!_X_78_X
M7R,?M'OL2++IJAAD;*\PZ#QNU1?^%D;,<"=^/P-=T_X",E\9Z]J4$;:3("HX
M3C\JXEN:GE7PY4-XEG!Y`0?SKLQ.T3*GNSV<#`P*XC4YGQS#&?#-Y(5^8(<&
MM*7QH4MCAOAY<Z9:PW;:C<PP@R97S'`R-HKHQ$6Y:(B#LM3J-%;2O$&KRWUG
M'AK21H4?/WE(!)KGG%PT92:>I@_$>XFLM?TZ[=-T$.<9Z;O3VR*WH)2BXOJ3
M-M-,T;/Q)X>U^P^PS`6T[KMV2\!OQZ5$J,X:H:DF7]-\*F+PM+HS3N\3[AO7
M@[22<?KBLW-N7,4E96-!]`M;+19%\L;E3CVXJ%N,\Z^'EO'<^(+A)%ROECC\
M379B=D94]V>D7/ANSCU"/443;+`I"D'H#UKC3:5C7S.;LDD?7YKB4!F=\@MV
M'05/*V['J1J0CAT=)<-!.-[*I?&!CM6T(6=SSJE1I<JV,R258869L#:IQGUK
M:3LKF5"FZE111S=\MM/;L[3LKYR58<'Z5R:/6Y[TU5I^[RZ#M9D6]\`22L/W
MD8`!_'%:T7:9XM>-FSFK674O!>K13C<87Z$]'']T^]=491K1Y7N<[3@[GKUC
MJEEXBT7[3$0V5Y'=3Z&N*47!V9JG=:&#\/((_(O#M_Y>91_X]5U?B%'8Q/BI
M"D<MIL7!;=_*M\+NR*AIV&M:%IGA)'N+B"2X2$?N5D!9CCIBL?92E*UB^9)'
M1^&+"UAMS>6J;%NL2L,Y^8@5G)N]F-'0U(SGO&K^7X5OV](F_E5T_B0GL<SX
M3TV+5?A\MNX!#QD'\S55':;:$E[MCS>SU*Y\+:Y(Q!\VV+(XZ;A_G!KK;52!
MFO=9ZAX#TB1-.DO[H$W-R3-(3ZGM^`XKCJ2NS5*R/,M6?R?%\Z]-MX#_`./"
MNQ2O3L9->\?0%F<Z8G^[7GFQXS9OGXI,OI._\JZY/]R9KXCV34/^03+_`+G]
M*Y$:'D7PR?=XGN1Z(/\`T(UUXAZ(SANSV6YNH+*VDN+F58H8U+,['``%<B5S
M0Y_QO*K^#[V1#E?+)!JZ>DT)['G7P^T&UUR&\:>*-V$FT%U!_A%;5Y/F)@M#
MM/#6BP^$;BY,UPL=O<3@1*>,$X`4>O-8RDY[E)6+FLSZ=J>L_P!AW<(W20>8
MCM@A^<$8]J23M=#\CB/$'PWDLHI+C3G*A1G83E3_`(5M"O):,AP3V.G^&.J7
M-]H)BN&9S#(R*3UP/\XJ:R7-H..QUVK?\@NX_P!PUDMRCR+X7ON\17/^XO\`
M,UTXAW2,X;GLERI>VD4>E<IH<.A0%H7.UTDQGN*VBDUJ.,Y0=D1QZP?M)65%
M\LG`8<$?6LXU==3U*F7)T[P>I9U"W^V6RM#(IYSUX-:S7/&R./"U?JM7]XCD
M=;)M%\LD;CTP:YG!Q=F>LL5"K%N);OH'MOAQ<%NN%_\`0A6U+XCPZ[YI-H[&
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ME+<[<*9%)4'W`J%:^HSQJ\\$^(KJ_ENI9HFFD?>6"$<ULJJ2M8GE/3O#4^OQ
M:/+#J+V\DZ+B(JA4=/XO_K5D[-Z%'"Q>&/$4/BHZOYELTID+D>6P7GMUK1U%
MR\I/+K<]*U&74Y?#A6`0+>,N"6!*#Z#K62T91YGX?\.>)=`U"2ZM9;7>XP3)
M$Q'7ZUK*HI;H2C8U[S3?%7B.ZBM]6U",V`8,T%O$4#X[$GM4J26R"U]SH_%E
MAJ=SX<_L^R:%3(NV0R*2<>V*F+L[C:..\-:3XJ\-QRI9RV@\QMQ,D+'G&/6K
ME-2U8DK&I9Z-XBUC7K>\UN^$Z6S;XH8H]B*W]['<U/,DK(+=S5\8>&+R_N;*
M^L+IK>[M,E'5<YSC@_E1&7*K`U<J33>+]0LC83W%G"CC:TL,3&0CV!.`:+Q6
MH['3^%="CT+34MXEVJHP,]?J?>I;;=PV&>+'U<V)ATIK="X(=ID+?EBA66X'
MFWAKPYXDT#5/M,$EL=PPPDC;!'X&M95%)68E&Q[);.\MLK2@!B.<>M8C.0\3
M:/<1S?;+/J#D@=ZJ,K`]3AKO5&AN"KQ,I/J.AK.25]#V,-BFH>]T-&#Q$EO8
MB!%R_4D#J:V@^56/,Q%3VT^898:5=:[?QR2J?+4YYJ9.Y,).":1M^,=&U>ZT
MQ-+T^2"*U('F;D)=B/TQ3A)1U,VKFYX/?5X;);;4S"^P`*T:D$_7-2[-W0R?
MQ5X7M=>T]XI(QNQD$=0?44)N+N@W,[P!H%SX?TZ2UN7$C>8S!@,9!Z4Y2YG<
M25CG_B#H.M>(-001/`MO%G8-C%CGUJH3Y!.-Q;-_&MCI<=G;7-C&J*%!^SL3
MQ^-*\;WL.S-GP9H%_9W=Q?ZE<O<WEP09)6&.!T`'8"B4K@E8[JH&(44]5!_"
M@!`B`\*/RH`7`]*``@$8(H`3RT_N#\J``(HZ*!^%`!Y:?W1^5`"[5QC`Q0`G
MEI_<'Y4``15Z*!^%`"E0>H!H`3RT_N#\J`%"JO10/PH`CN;B&TMY)[AUCBC!
M9F;H!0!2CU2T:XBB,,B-+]QFCX/&>O;\:`)[K4;>S>..1B99,[(U&6;'4X]/
M>@!MOJ-M=S/`%998P"R.N.#T/H>AHV`;;:A97=U=6\)!DM7"2`KC!(S_`"(H
M:L!!'X@LI//\E9I!;NT<FR/.&'4>].U@+-S?6L>F/>S9-NJ;S\I)QC/3K0E<
M#GKNUT&_TY-2C826\I4*T:Y.2<#CZG\*+,+D,GA[2=.D5I$=N"WR)D`#UHM<
M#9T:]TR9(A8H^R2/S$=HR`R^Q_&AJP%VWU*SO+NYMHSNEMF"R`KT)&1^E%@*
M\>O6+^>88Y9/(=HY-D><,.H]Z+`3W6KV=EIG]H3N5M@`2=IR`>G'XT)7T`EG
MOK:SMC<32".,8&?4GH!ZFD!`FJ6KW$4+Q21O+D)O3AL#/7MQZT[`7_+3^X/R
MI`*`!P!B@!:`"@`H`*`"@`H`*`"@`H`*`"@`H`*`"@#*\01)/I$T,ELURD@V
MM$N,L#UZTUN!REE:ZC8ZG9BSN;I[/=B:.Y^8!<<;2><YQ3NNH6+FHVUW%XQ@
MU%D:6T-N86"\E#NSG'<'^E%]+!U.@M9XI;AQ'!*BJ.'<8W'T`ZU(&%H,,\?B
M#7'DA=(Y9PT;,.&&P#(_$53>PD96F6TJSZJ)XKV(27;R)Y7!9>,$<^U-@CI]
M0=KGPS*5@E$CQ\1@9<$]OK4K<9S-WIE]I=VDNG1E[2ZE0W$'3:=P/F+Z'U'>
MJ3745CKM1B#:),P5F;RSA1U/%2MQE#P;:O#X<LXYXFCFCA561NH(&*);ALBI
MHD4\?B36Y)(72.6161F'#`(`<?B*;>B#J4M$TJXGGU5)/M-OYEV[H5;;E3C!
M%#>P+0U/&5K/)X4G@@B>69L81!R?F%$79@RIXBM+RZL=,FM@7^RW*S-'G&\#
M/'UYS^%"=K@S:M[J%V@1;:;)^\S+M"<>_7\*0&T.@Q2`6@`H`*`"@`H`*`"@
M`H`*`"@`H`*`"@`H`*`(;D`Q'(H`JPJ-PX%"`ENE''`H`;;@;N@H`2)0)FX%
M`%<JH=OE'Y4`6E`^S]!0`,JF)<J/RI`2R`?9L8XQ3`;:`",X`%`$<:J)VX%`
F"VJ@2M@`4`278!C&1F@!I5?LP&!0!!$H\P<"D!HCI3`*`"@#_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
